Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001079973 | SCV000561037 | benign | Developmental and epileptic encephalopathy, 12 | 2024-01-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313226 | SCV000847472 | likely benign | Inborn genetic diseases | 2018-04-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000828396 | SCV000970082 | likely benign | not provided | 2023-11-03 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Prevention |
RCV003972791 | SCV004789021 | benign | PLCB1-related condition | 2023-10-18 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |